Clinical Trials Browser

Phase 1 × Mesothelioma, Malignant × Dasatinib × Clear all

NCT00652574 2022-10-31

Dasatinib in Resectable Malignant Pleural Mesothelioma

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant